ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option
Fund House: ICICI Prudential Mutual Fund| Category: Equity: Sectoral-Pharma and Healthcare |
| Launch Date: 05-07-2018 |
| Asset Class: Equity |
| Benchmark: S&P BSE Healthcare TRI |
| Expense Ratio: 2.07% As on (30-06-2022) |
| Status: Open Ended Schemes |
| Minimum Investment: 5000.0 |
| Minimum Topup: 1000.0 |
| Total Assets: 2,502.71 Cr As on (31-07-2022) |
| Turn over: 54% | Exit Load: 1% for redemption within 15 days |
19.14
-0.15 (-0.7837%)
17.55%
S&P BSE Healthcare TRI 12.26%
PERFORMANCE
Fund Multiplier
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
Investment Objective
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Current Asset Allocation (%)
Indicators
| Volatility | |
| Sharp Ratio | 0.9 |
| Alpha | 3.39 |
| Beta | 0.96 |
| Yield to Maturity | - |
| Average Maturity | - |
PEER COMPARISON
| Scheme Name | Inception Date |
1 Year Return(%) |
2 Year Return(%) |
3 Year Return(%) |
5 Year Return(%) |
10 Year Return(%) |
|---|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option | 05-07-2018 | -9.16 | 12.1 | 25.86 | - | - |
| Mirae Asset Healthcare Fund -Regular Growth | 10-07-2018 | -6.77 | 14.69 | 29.17 | - | - |
| Tata India Pharma & Healthcare Fund-Regular Plan-Growth | 28-12-2015 | -7.75 | 11.97 | 22.75 | 15.56 | - |
| SBI Healthcare Opportunities Fund - Regular Plan -Growth | 14-07-1999 | -8.37 | 11.08 | 24.68 | 12.61 | 14.78 |
| DSP Healthcare Fund - Regular Plan - Growth | 05-11-2018 | -9.01 | 12.86 | 28.02 | - | - |
| Nippon India Pharma Fund-Growth Plan-Growth Option | 01-06-2004 | -9.81 | 12.47 | 25.8 | 18.21 | 16.28 |
| UTI Healthcare Fund - Regular Plan - Growth Option | 05-08-2005 | -10.98 | 9.22 | 23.7 | 13.47 | 12.94 |
| Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | 05-07-2019 | -11.4 | 8.77 | 18.94 | - | - |
| IDBI Healthcare Fund - Regular Plan - Growth | 22-02-2019 | -11.99 | 6.74 | 20.7 | - | - |
Scheme Characteristics
Minimum investment in equity & equity related instruments of a particular sector/ particular theme - 80% of total assets.
Riskometer
PORTFOLIO
Market Cap Distribution
Small Cap
17.24%
Others
7.63%
Large Cap
43.89%
Mid Cap
31.24%
Tax Benefits of investing in this fund
Long term capital gains (LTCG) tax @10% (plus surcharge, if applicable and cess) without indexation if units held for more than 12 months#
Short term capital gains (STCG) tax @ 15% (plus surcharge, if applicable and cess) if units are held for less than 12 months.
Investor does not pay any tax on dividends but a Dividend Distribution Tax (DDT) is deducted at source @11.648% (10% + 12% surcharge + 4% Health & education cess) **
# Capital gain accrued up to January 31st 2018 is exempt from LTCG tax in respect of units acquired before January 31, 2018 & redeemed on or after April 1, 2018. ** The DDT is to be paid by the mutual fund
